INSIDER · PVLA · PALVELLA THERAPEUTICS, INC. · CHIEF SCIENTIFIC OFFICER

Martini Jeffrey S

Every open-market transaction filed under this name, Nov 10 to Nov 11.

Filings

0 buys · 13 sells

Bought

—

open market, at cost

Sold

$2.1M

includes scheduled sales

Buys since

—

no current price on file

Filings

SEC FORM 4 · OPEN MARKET

Traded	Ticker	Company	Role	Type	Shares	Price	Value	Since
Nov 11	PVLA	PALVELLA THERAPEUTICS, INC.	Chief Scientific Officer	Sell	200	$169.78	$34K	−10.2%
Nov 11	PVLA	PALVELLA THERAPEUTICS, INC.	Chief Scientific Officer	Sell	600	$168.73	$101K	−9.6%
Nov 11	PVLA	PALVELLA THERAPEUTICS, INC.	Chief Scientific Officer	Sell	1,200	$167.75	$201K	−9.1%
Nov 11	PVLA	PALVELLA THERAPEUTICS, INC.	Chief Scientific Officer	Sell	1,133	$166.76	$189K	−8.6%
Nov 11	PVLA	PALVELLA THERAPEUTICS, INC.	Chief Scientific Officer	Sell	1,467	$165.78	$243K	−8.0%
Nov 11	PVLA	PALVELLA THERAPEUTICS, INC.	Chief Scientific Officer	Sell	1,650	$164.14	$271K	−7.1%
Nov 10	PVLA	PALVELLA THERAPEUTICS, INC.	Chief Scientific Officer	Sell	800	$172.12	$138K	−11.4%
Nov 10	PVLA	PALVELLA THERAPEUTICS, INC.	Chief Scientific Officer	Sell	550	$169.03	$93K	−9.8%
Nov 10	PVLA	PALVELLA THERAPEUTICS, INC.	Chief Scientific Officer	Sell	200	$167.81	$34K	−9.1%
Nov 10	PVLA	PALVELLA THERAPEUTICS, INC.	Chief Scientific Officer	Sell	1,500	$166.91	$250K	−8.6%
Nov 10	PVLA	PALVELLA THERAPEUTICS, INC.	Chief Scientific Officer	Sell	1,651	$165.85	$274K	−8.1%
Nov 10	PVLA	PALVELLA THERAPEUTICS, INC.	Chief Scientific Officer	Sell	1,449	$164.85	$239K	−7.5%
Nov 10	PVLA	PALVELLA THERAPEUTICS, INC.	Chief Scientific Officer	Sell	100	$163.34	$16K	−6.6%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.